TSOI Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 22:57):

Stats
Dzisiejszy wolumen	41.54M
Średni wolumen	19.78M
Kapitalizacja rynkowa	2.54M
EPS	$0 ( 2024-04-01 )
Następna data zysków	( $0 ) 2024-05-16
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Dixon Timothy G	Buy	42 857 142	Common Stock
2024-04-18	Ichim Thomas	Buy	15 000 000	Common Stock
2024-02-26	Ichim Thomas	Buy	10 000 000	Common Stock
2024-02-26	Dixon Timothy G	Buy	10 000 000	Common Stock
2023-10-16	Ichim Thomas	Buy	20 000 000	Common Stock

INSIDER POWER
96.82
Last 93 transactions
Buy: 846 892 711 \| Sell: 287 531 261

Therapeutic Solutions Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Therapeutic Solutions Finanse

Annual	2023
Przychody:	$98 994.00
Zysk brutto:	$-682 876 (-689.82 %)
EPS:	$-0.000700

FY	2023
Przychody:	$98 994.00
Zysk brutto:	$-682 876 (-689.82 %)
EPS:	$-0.000700

FY	2022
Przychody:	$206 767
Zysk brutto:	$127 327 (61.58 %)
EPS:	$-0.00150

FY	2021
Przychody:	$145 956
Zysk brutto:	$103 412 (70.85 %)
EPS:	$-0.00131

Financial Reports:

No articles found.

Therapeutic Solutions

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products include QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPlus, a blend of NanoStilbene and Nano Cannabidiol; Nano Cannabidiol, a nanoparticle formulation of cannabidiol; NanoPSA, a blend of NanoStilbene and broccoli sprout extract; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. It is also developing therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is based in Elk City, Idaho.